uvi-3003 and Eye-Abnormalities

uvi-3003 has been researched along with Eye-Abnormalities* in 1 studies

Other Studies

1 other study(ies) available for uvi-3003 and Eye-Abnormalities

ArticleYear
Effects of antagonist of retinoid X receptor (UVI3003) on morphology and gene profile of Xenopus tropicalis embryos.
    Environmental toxicology and pharmacology, 2014, Volume: 38, Issue:1

    We exposed Xenopus tropicalis embryos to a selective antagonist of retinoid X receptor (UVI3003). UVI3003 induced multiple malformations at the concentrations of 200-1000 μg/L after 48 h exposure. The most prominent malformations affected brains, eyes, cement gland and fins. UVI3003 also induced variable and divergent malformations at 250-1500 μg/L after 0-24 and 24-48 h exposure. Microarray analysis showed that seven genes (rps15, serp2, fmr1, cyp2e1, lrrc9, ugtla6 and LOC100490188) were differentially regulated in all three treatment groups after 0-24h exposure. The most significantly affected pathway was galactose metabolism. In 24-48 h exposure groups, 18 genes were differentially regulated, mainly comprising components of the PPAR signaling pathway. These results suggested that UVI3003 is teratogenic in amphibian embryos. Differential gene expression suggests that galactose metabolism and PPAR signaling pathways may provide underlying mechanistic detail accounting for the observed malformations.

    Topics: Animal Fins; Animals; Brain; Coumaric Acids; Embryo, Nonmammalian; Eye Abnormalities; Galactose; Gene Expression Profiling; Gene Expression Regulation, Developmental; Peroxisome Proliferator-Activated Receptors; Retinoid X Receptors; Teratogens; Tetrahydronaphthalenes; Xenopus

2014